Se connecter

Bibliographies thématiques / Drug beroduat

Sommaire

Articles de revues

Littérature scientifique sur le sujet « Drug beroduat »

Auteur : Grafiati

Publié le 7 juin 2025

Mis à jour le 2 août 2025

Créez une référence correcte selon les styles APA, MLA, Chicago, Harvard et plusieurs autres

Choisissez une source :

Consultez les listes thématiques d’articles de revues, de livres, de thèses, de rapports de conférences et d’autres sources académiques sur le sujet « Drug beroduat ».

À côté de chaque source dans la liste de références il y a un bouton « Ajouter à la bibliographie ». Cliquez sur ce bouton, et nous générerons automatiquement la référence bibliographique pour la source choisie selon votre style de citation préféré : APA, MLA, Harvard, Vancouver, Chicago, etc.

Vous pouvez aussi télécharger le texte intégral de la publication scolaire au format pdf et consulter son résumé en ligne lorsque ces informations sont inclues dans les métadonnées.

Articles de revues sur le sujet "Drug beroduat"

1

Balunov, Р. A., and A. N. Khitrov. "Pharmacoeconomic aspects of the use of bronchodilators in the management of COPD: real clinical practice." Medical Council, no. 21 (January 20, 2019): 96–104. http://dx.doi.org/10.21518/2079-701x-2018-21-96-104.

Texte intégral

Résumé :

Today, chronic obstructive pulmonary disease is the fourth global cause of deaths worldwide. A number of studies showed that 11 to 16 million people might suffer from the chronic obstructive pulmonary disease in Russia. The prevalence and high mortality of this disease lead to a significant socio-economic burden. A pharmacoeconomic comparison of two alternative drug technologies in the studied groups grants the reasonable opportunity to transfer patients to the domestic analogues, confirming that efficiency unit costs for using Tiotropium-native and Ipraterol-native are lower than the same cos

Styles APA, Harvard, Vancouver, ISO, etc.

2

Kazakov, Yu M., T. V. Nastroga, N. M. Motorna, O. E. Kitura, and N. L. Sokolyuk. "Optimised Complex Therapy of Chronic Obstructive Pulmonary Disease Exacerbation in Elderly Patients (Review)." Tuberculosis, Lung Diseases, HIV Infection, no. 2 (May 29, 2025): 101–5. https://doi.org/10.30978/tb2025-2-101.

Texte intégral

Résumé :

Chronic obstructive pulmonary disease (COPD) is one of the most important medical and social problems, as it ranks third among the leading causes of death worldwide. Objective — to optimise the treatment of elderly patients with COPD, GOLD II, group B, using sequential nebuliser delivery of the mucolytic drug acetylcysteine and the respiratory cytoprotector ectoine (ectobrise) against the background of basic therapy. Materials and methods. 60 elderly patients with COPD, group B, were observed. Patients in the control group (n = 30) received complex basic therapy, which included an antibacteria

Styles APA, Harvard, Vancouver, ISO, etc.

3

Y. M. Mostovoy, Y. M., T. V. Konstantinovych, O. R. Lindiuk, and O. V. Bugaichuk. "RECOMMENDATIONS ON COPD AND FAMILY PRACTITIONERS: WHAT IS THE LEVEL OF ADHERENCE?" Ukrainian Pulmonology Journal 29, no. 4 (2021): 15–18. http://dx.doi.org/10.31215/2306-4927-2021-29-4-15-18.

Texte intégral

Résumé :

Y. M. Mostovoy, T. V. Konstantinovych, O. R. Lindiuk, O. V. Bugaichuk Abstract Majority of COPD patients should receive medical care provided by family practitioners. Only the cases of severe, uncontrolled diseases must be managed by pulmonologists. That is why family practitioners must be well informed on actual requirements on diagnosis and treatment of COPD in order to give effective care to this population of patients. Following the aim to study quality of medical care, provided to COPD patients by family practitioners, we analyzed 220 out-patient records (95 men (43,2 %), 125 women (56,8

Styles APA, Harvard, Vancouver, ISO, etc.

4

Kirieieva, T. V., N. K. Kravchenko, and B. O. Basina. "STANDARDS FOR TREATMENT OF PATIENTS WITH COPD IN 2024: PLACE FOR TIOTROPIUM BROMIDE." Ukrainian Pulmonology Journal 32, no. 2 (2024): 55–58. http://dx.doi.org/10.31215/2306-4927-2024-32-2-55-58.

Texte intégral

Résumé :

Updated GOLD 2024 guidelines emphasized the problem of insufficient or inaccurate diagnosis of COPD, leading to inappropriate therapy of these patients. This trend is also widespread in Ukraine, despite the significant improvement in diagnosis and available treatment options. The aim of the study was to determine the effectiveness of tiotropium bromide (Spiriva® HandiHaler® "Boehringer Ingelheim Pharma GmbH", Germany) for the initial and follow-up treatment of patients. We evaluated the effect of the drug on the clinical and functional status of patients and adherence to therapy. Materials and

Styles APA, Harvard, Vancouver, ISO, etc.

5

L.V., Kadomtseva, Daminov R.U., Valieva T.A., Mirzakarimova F.R., and Kaleda S.P. "USE OF NEBULIZER THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND CARDIOVASCULAR COMORBIDITY." May 6, 2025. https://doi.org/10.5281/zenodo.15347598.

Texte intégral

Résumé :

<em>Chronic obstructive pulmonary disease (COPD) is characterized by persistent and usually progressive airflow limitation associated with various risk factors, the main one being tobacco smoking. The increasing role of this pathology among the causes of morbidity and mortality is well known. It should be noted that in recent years there has been a greater understanding of the complexity of this disease in terms of an integrated clinical assessment of severity, pathophysiology and relationship with other pathologies. Chronic obstructive pulmonary disease is a disease of the second half of life

Styles APA, Harvard, Vancouver, ISO, etc.

6

Zherebtsova, N. Yu, and T. V. Kajdanek. "Local and systemic adverse reactions following COVID-19 vaccine (clinical report)." Russian Journal of Infection and Immunity, May 12, 2022. http://dx.doi.org/10.15789/2220-7619-las-1817.

Texte intégral

Résumé :

The mass vaccination against novel coronavirus infection (COVID-19) requires to dynamically evaluate risks of adverse events following immunization to prevent them and develop vaccination tactics for various population groups. We describe a clinical case of reaction following administration of the second dose of the heterologous recombinant adenovirus based COVID-19 vaccine Gam-COVID-Vac (Sputnik V) in 48-year-old female healthcare worker. No adverse events after administration of the first dose were recorded. After vaccination, the patient complained of weakness, malaise, headache, loss of ap

Styles APA, Harvard, Vancouver, ISO, etc.

Nous offrons des réductions sur tous les plans premium pour les auteurs dont les œuvres sont incluses dans des sélections littéraires thématiques. Contactez-nous pour obtenir un code promo unique!